市場調査レポート
商品コード
1149503
いびき防止装置市場:洞察、競合情勢、市場予測:2027年Anti-Snoring Devices Market Insights, Competitive Landscape and, Market Forecast - 2027 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
いびき防止装置市場:洞察、競合情勢、市場予測:2027年 |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 100 Pages
納期: 2~10営業日
|
世界のいびき防止装置の市場規模は、2021年に14億米ドルとなりました。同市場は、2022年~2027年の予測期間中に7.22%のCAGRで拡大し、2027年には21億3,000万米ドルに達すると予測されています。同市場は、人々の間で肥満が増加していることや、高齢者人口の増加など、さまざまな要因によって成長が見込まれています。
当レポートでは、世界のいびき防止装置市場について調査し、市場の概要とともに、装置タイプ別、外科手技別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
ANTI-SNORING DEVICES MARKET BY DEVICE TYPE (MANDIBULAR ADVANCEMENT DEVICES [MAD], TONGUE STABILIZING DEVICES [TSD], CONTINUOUS POSITIVE AIRWAY PRESSURE [CPAP] DEVICES, AND OTHERS), BY SURGICAL PROCEDURE (UVULOPALATOPHARYNGOPLASTY [UPPP], SOMNOPLASTY, PILLAR PROCEDURE, TONSILLECTOMY, RADIOFREQUENCY PALATOPLASTY, AND OTHERS), BY END-USER (HOSPITALS, SLEEP THERAPY CLINICS, HOMECARE, AND OTHERS), AND BY GEOGRAPHY IS EXPECTED TO GROW AT A STEADY CAGR FORECAST TILL 2027 OWING TO INCREASING OBESITY AND ELDERLY POPULATION ACROSS THE GLOBE AND THE LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS IN THE MARKET.
The global anti-snoring devices market was valued at USD 1.40 billion in 2021, growing at a CAGR of 7.22% during the forecast period from 2022 to 2027 to reach USD 2.13 billion by 2027. The anti-snoring devices market is witnessing positive growth owing to various factors such as the increasing obesity among the people and rising number of elderly population. Also, the increasing smoking and alcohol consumption, the rising prevalence of sleep apnea and the technological advancements in the market pertaining to the anti-snoring devices along with the product launches and approvals, and others are offering prominent opportunities for the market growth. Therefore, the market for anti-snoring devices are estimated to grow at a significant CAGR during the forecast period from 2022 to 2027.
One of the main drivers of the anti-snoring devices market is the increasing burden of obesity and overweight among the people across the globe.
For instance, according to the data published by the World Health Organization (WHO) in 2021, stated that in 2019, an estimated 38.2 million children under the age of 5 years were overweight or obese. Also, the source concluded that almost half of the children under 5 years who were overweight or obese in 2019 lived in Asia. The obesity is more likely to cause snoring and obstructive sleep apnea as neck fat compresses the upper airway, particularly when lying down, making snoring much more likely. Also, the central obesity, where fat is found around the midriff and chest, also worsens snoring and sleep apnea. Thus, the obesity will increase the prevalence of obstructive sleep apnea and snoring, ultimately increasing the demand of snoring management and treatment devices in the upcoming years.
Further, the increasing geriatric burden across the globe will aid in propelling the market of anti-snoring devices during the study period (2022 - 2027). As per WHO 2022, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years, across the globe. The data provided by the above mentioned source estimated that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion, in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The number of persons aged 80 years or older was also provided by the same source, which is expected to triple between 2020 and 2050 to reach 426 million, globally. The geriatric people are more prone to snoring and sleep apnea as with aging, the apparent weakening and loss of tone of upper airway muscles during sleep predisposes to airway obstruction that leads to snoring and sleep apnea.
Thus, the escalating burden of elderly population across the globe will increase the demand of anti-snoring devices in the market.
Therefore, the factors stated above collectively will drive the overall anti-snoring devices market during the forecast period from 2022-2027.
However, high costs of custom-made oral devices, poor efficacy and lack of scientific validation of the anti-snoring devices among people and physicians, and others, can impede the global anti-snoring devices market growth.
The COVID-19 epidemic has moderately impacted the anti-snoring devices market as the pandemic led to a fall in sales of anti-snoring devices. The fall in sales can be attributed to a reduced number of elective surgeries being carried out. Moreover, severe disruption in the supply chain, shortage of raw material and other resources due to the lockdowns and restrictions, the manufacturing of the devices was halted. The pandemic also resulted in fewer hospital visits by the patients owing to the lockdown impositions. All of this led to a slightly negative impact on the market. However, with the ease of lockdown restrictions, upturn of resources and supply chain, the administration of vaccine among the public, the increasing hospitalization number for surgical methods
, and with the increasing demand of devices through e-commerce platforms, the market of anti-snoring devices picked up the momentum again and is expected to do the same in the upcoming years.
Anti-Snoring Devices Market By Device Type (Mandibular Advancement Devices [MAD], Tongue Stabilizing Devices [TSD], Continuous Positive Airway Pressure [CPAP] Devices, and Others), Surgical Procedure (Uvulopalatopharyngoplasty [UPPP], Somnoplasty, Pillar Procedure, Tonsillectomy, Radiofrequency Palatoplasty, and Others), End-User (Hospitals, Sleep Therapy Clinics, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the device type segment of the anti-snoring devices, the continuous positive airway pressure (CPAP) market is expected to have a significant revenue share in the year 2021. This was primarily owing to the increasing demand of CPAP device during the pandemic.
Continuous positive airway pressure (CPAP) devices are used in airway blockages to open up the blocked airways by pushing air into them. The CPAP has a pump that controls the air pressure in the system and consists of a tube carrying air toward the mask attached to the nose and mouth. CPAP devices help ease the functioning of the airway and help the person get a night of sound sleep, increasing their demand. Thus, the demand for CPAP machines and masks increased since CPAP devices shows beneficial effects on managing the symptoms of COVID-19, such as ease of breathing and chest congestion.
Further, the increasing launches in the market by the key players aids in propelling the demand of CPAP in the market. For instance, in June 2019, InnAccel introduced SAANS, a CPAP system in the market. It is the world's first infrastructure-independent, portable, and neonatal CPAP system that provides constant air flow, preventing the airway from collapsing. Also, it eliminates the vibration of tissue that causes snoring.
Also, in August 2021, ResMed released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea and snoring.
Thus, due to the interplay of all the factors mentioned above, this can result in the rising demand for continuous positive airway pressure, which in turn would provide a conducive growth environment for overall anti-snoring devices market during the market forecast 2022-2027.
Among all the regions, North America is expected to dominate the global anti-snoring devices market in the year 2021 and is expected to do the same during the forecast period from 2022-2027.
Factors such as the increasing prevalence of sleep apnea among the people in the region, and the rising obesity, and elderly population will spur the demand of the anti-soring devices in the region. Further, the growing consumer awareness regarding the importance of snoring management devices, presence of key players, and other are anticipated to drive the market of anti-snoring devices in the North America during the forecast period of 2022 - 2027.
For instance, as per the latest data published by the National Center for Biotechnology Information, 1 in 15 people present with moderate to severe symptoms of the sleep disorder, in the United States. Also, obstructive sleep apnea (OSA) may affect as many as 37% of adults in North, Central and South America, according to the latest study Associated Professional Sleep Societies.
Further, according to the data of Sleep Foundation (2019), in the United States, in 2019, about 57% of the men and 40% of the women were living with the snoring condition. Thus, from the above-mentioned figures it can be concluded that the prevalence of sleep apnea and snoring is quite high in the United States, leading to the increased demand of anti-snoring devices in the market.
Moreover, as per the Centers for Disease Control and Prevention, 2019, all US states and territories have an obesity rate of at least 20%, in 2019. The source also stated that about 18.5% of children ages 2 to 19 were considered as obese in the United States, in 2019. The increasing obesity among the people in the region will increase the demand of anti-snoring devices as the obese and overweight people are more prone to snoring due to the presence of excessive fat accumulation near neck or chest which may cause narrowing of airways, causing snoring, ultimately leading to the increased demand of snoring management and treatment devices, thereby propelling the overall market of anti-snoring devices in the North America during 2022 - 2027.
Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the anti-snoring devices.
Some of the key market players operating in the anti-snoring devices market include Fisher & Paykel Healthcare Limited., Koninklijke Philips N.V., ResMed., Tomed GmbH., Apnea Sciences, Rotech Healthcare Inc., Meditas, Mitsui Chemicals, Inc., SomnoMed, The Pure Sleep Company, GSK plc., Airway Management., HIVOX BIOTEK INC., Ripsnore, Oniris, ZYPPAH, Mpowrx™ Health and Wellness Products, Contour Products, Inc., Sleeping Well LLC, Inovatives Health Technologies Inc., and others.
Anti-snoring treatment devices refers to the type of equipment utilized to prevent snoring. Snoring is characterized as a vibration of the respiratory tract due to obstruction in the airway flow.
The global anti-snoring devices market was valued at USD 1.40 billion in 2021, growing at a CAGR of 7.22% during the forecast period from 2022 to 2027 to reach USD 2.13 billion by 2027.
The anti-snoring devices is witnessing an affirmative market growth due to the factors such as increasing obesity among the people and rising burden of geriatric population. Also, the increasing smoking and alcohol consumption, rising prevalence of sleep apnea, technological advancements pertaining to anti-snoring devices along with the product launches and approvals, and others will drive the market of anti-snoring devices in the forecast period.
Some of the key market players operating in the anti-snoring devices include Fisher & Paykel Healthcare Limited., Koninklijke Philips N.V., ResMed., Tomed GmbH., Apnea Sciences, Rotech Healthcare Inc., Meditas, Mitsui Chemicals, Inc., SomnoMed, The Pure Sleep Company, GSK plc., Airway Management., HIVOX BIOTEK INC., Ripsnore, Oniris, ZYPPAH, Mpowrx™ Health and Wellness Products, Contour Products, Inc., Sleeping Well LLC, Inovatives Health Technologies Inc., and others
North America is expected to dominate the global anti-snoring devices. Factors contributing to the growth are the increasing prevalence of sleep apnea among the people, rising obesity, growing consumer awareness regarding the importance of snoring management devices, and others, are contributing to the growth of the anti-snoring devices in the North America region.